Key result
Non-obese OSA is linked to higher endothelial microparticles and lower progenitor cells versus controls.
Why the study?
Does CPAP therapy improve endothelial repair capacity and reduce endothelial apoptosis in non-obese patients with obstructive sleep apnea?
Case-Control (n=32)
Does CPAP therapy improve endothelial repair capacity and reduce endothelial apoptosis in non-obese patients with obstructive sleep apnea?
p-value: p=<0.001
In non-obese patients, obstructive sleep apnea impairs endothelial repair capacity and promotes apoptosis, which is partially reversible with 4 weeks of CPAP therapy.
Supports endothelial impairment in non-obese OSA; hypothesis-generating for CPAP effects on repair capacity.
PURPOSE: To investigate the impact of obstructive sleep apnea (OSA) on endothelial repair capacity and apoptosis in the absence of potentially confounding factors including obesity. PATIENTS AND METHODS: Sixteen patients with a body mass index <30 and newly diagnosed OSA and 16 controls were studied. Circulating levels of endothelial progenitor cells, a marker of endothelial repair capacity, and endothelial microparticles, a marker of endothelial apoptosis, were quantified before and after four-week therapy with continuous positive airway pressure (CPAP). Endothelial cell apoptotic rate was also quantified in freshly harvested venous endothelial cells. Vascular reactivity was measured by flow-mediated dilation. RESULTS: Before treatment, endothelial microparticle levels were greater and endothelial progenitor cell levels were lower in patients with OSA than in controls (P < 0.001 for both). Levels of endothelial microparticles and progenitors cells were inversely related (r = -0.67, P < 0.001). Endothelial progenitor cell levels increased after effective treatment (P = 0.036). CONCLUSIONS: In the absence of any co-morbid conditions including obesity, OSA alone impairs endothelial repair capacity and promotes endothelial apoptosis. These early endothelial alterations may underlie accelerated atherosclerosis and increased cardiovascular risk in OSA.
No takes yet. Share an insight, caveat, or question.
Sanja Jelić (2009) conducted a case-control in Obstructive sleep apnea (n=32). Obstructive sleep apnea vs. Controls without obstructive sleep apnea was evaluated on Circulating levels of endothelial progenitor cells and endothelial microparticles (p=<0.001). Obstructive sleep apnea in non-obese patients was associated with greater endothelial microparticle levels and lower endothelial progenitor cell levels compared to controls (P<0.001 for both).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: